Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PLEL gel refers to a thermosensitive hydrogel composed of poly(L-lactide-co-ethylene glycol-co-L-lactide), commonly abbreviated as PLEL. This material is a synthetic copolymer that forms a sol at low temperatures and transitions into a gel at body temperature. It is primarily used as an injectable or topical drug delivery system, enabling sustained and localized release of various therapeutic agents (such as chemotherapeutics, antibiotics, or proteins). The mechanism of action depends on the active ingredient loaded into the hydrogel; the polymer itself acts as an inert carrier matrix. The main application for PLEL gels has been in experimental settings for controlled drug delivery in oncology, wound healing, and tissue engineering.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on PLEL gel.